MyAverix Finance
F · Healthcare
NEWBURY PHARMACEUTICALS (P52)
Drug Manufacturers - Specialty & Generic
NEWBURY PHARMACEUTICALS (P52) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $972,732, P/E ratio is 18.00, net margin is -70.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for P52
NEWBURY PHARMACEUTICALS (P52) — FAQ
What is NEWBURY PHARMACEUTICALS's market cap?
NEWBURY PHARMACEUTICALS (P52) has a reported market cap of $972,732 (data as of 2026-03-30).
What is P52's P/E ratio?
The price-to-earnings (P/E) ratio for NEWBURY PHARMACEUTICALS (P52) is 18.00 (data as of 2026-03-30).
Does NEWBURY PHARMACEUTICALS pay a dividend?
Dividend yield is not available in the current snapshot for NEWBURY PHARMACEUTICALS (P52). Check the MyAverix Finance app for the latest dividend data.
What sector is NEWBURY PHARMACEUTICALS in?
NEWBURY PHARMACEUTICALS (P52) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is P52 listed on?
P52 is listed on F.
What is NEWBURY PHARMACEUTICALS's net margin?
NEWBURY PHARMACEUTICALS (P52) reports a net margin of -70.1% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.